Karyopharm Therapeutics Inc. - 8-K Filing

Karyopharm Therapeutics extended the Forbearance Period under its Forbearance Agreement from October 15 to October 22, 2026. (Items: 8.01 Other Items)

SEC EDGAR ·

Tickers: $KPTI

Read the full article at SEC EDGAR

More Regulatory news